Indicator summary: Leaning bearish (1 bullish, 3 bearish, 1 neutral). As of 2026-10-16, the close was $124.27: 6.3% below the 50-day average and 1.1% below the 200-day average, which is rising. RSI (14) is 38, in its neutral range. MACD is bearish after a cross in the last 10 days. The stock sits 58% of the way up its 52-week range of $93.04 to $147.22, on 1.0x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $132.67 | Price 6.3% below |
| 200-day average | $125.64 | Price 1.1% below, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 38 | Neutral range |
| MACD (12, 26, 9) | -2.45 vs -1.91 | Bearish cross in the last 10 days |
| 52-week range | $93.04 to $147.22 | 58% of the way up the range |
| Volume vs 20-day average | 1.0x | Normal |
Base rates use C's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-16, C's 14-day RSI is 38, which is in the neutral range between 30 and 70.
No. C closed at $124.27 on 2026-10-16, 1.1% below its 200-day average of $125.64, which is rising. When it closed below its 200-day average (2,761 days), it was higher 63 trading days later 57% of the time, median +2.1%.
No. C closed at $124.27 on 2026-10-16, 6.3% below its 50-day average of $132.67. When it closed below its 50-day average (2,819 days), it was higher 63 trading days later 59% of the time, median +3.0%.
Yes, a bearish cross within the last 10 trading days. As of 2026-10-16 the MACD line is -2.45 against a signal line of -1.91, so MACD is bearish.
No. At $124.27 it sits 58% of the way up its 52-week range of $93.04 to $147.22, 15.6% below the high.
Leaning bearish: 1 of 5 indicators are bullish and 3 bearish as of 2026-10-16 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Buy, from the chart signal model.
C analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.